Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Ahmad Wehbe, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT01588431
First received: February 29, 2012
Last updated: October 24, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2022
  Estimated Primary Completion Date: December 2021 (Final data collection date for primary outcome measure)